Startups
Seqens
Edit

Seqens

http://www.novacap.eu/
Last activity: 30.09.2021
Active
Categories: CareChemicalsCosmeticFoodTechHealthTechHomeIndustryITMedtechProduct
Seqens is an integrated global leader in pharmaceutical synthesis and specialty ingredients with 24 manufacturing sites and 7 R&D centers in Europe, North America and Asia.
Mentions
10

Investors 1

DateNameWebsite
Sign up to seeSign up to seeSign up to see

Mentions in press and media 10

DateTitleDescription
Sign up to seeSign up to seeSign up to see
Feb 17, 2021Novacap Closes TMT VI at US$1.865 BillionWith strong demand, TMT VI was significantly oversubscribed, exceeding its target of US$1 billion. Virtually all investors in the firm's TMT V vehicle committed to TMT VI, while adding important new investors from the US, Europe, Asia ...
Nov 21, 2019NOVACAP CLOSES INDUSTRIES FUND AT C$940 MILLIONNovacap Industries V aims to invest in companies with strong growth potential in the industrial and manufacturing sectors as well as in service and distribution. The Fund will maintain its current strategy of investing in North American mid...
Jul 20, 2017Novacap closes TMT V Fund at $840 MillionMONTREAL, Quebec, July 20, 2017 – Novacap, one of Canada’s leading private equity firms, today announced it has closed its latest private equity fund, NOVACAP TMT V (the ‘’Fund’’), at its hard cap with total commitments of $840 million. The...
May 25, 2016NOVACAP announces the closing of its NOVACAP Industries IV Fund at $ 470 millionThe NOVACAP Industries IV Fund, which aims to invest in companies with strong growth potential in the industrial and manufacturing sectors as well as in service and distribution, was launched in October 2014 with an initial target of $ 425 ...
May 11, 2016Novacap closes latest fund above target at $470mCanadian private equity firm Novacap has closed its fourth fund at $470m, putting its 11 per cent above its initial ta
Oct 22, 2014NOVACAP launches NOVACAP Industries IV, a new investment fund with a goal of raising $425 millionNOVACAP has already completed commitments for an initial $300-million investment in NOVACAP Industries IV and expects to meet its $425-million goal in the next few months. This initial closing was financed mainly by the Caisse de dépôt et p...
May 13, 2014NOVACAP Closes Fourth Private Equity Fund at $375 Million“After the success and momentum of the Novacap Technologies III fund, we are proud to launch NOVACAP TMT IV, which aims at filling a void in the TMT sector in Canada. In fact, for several years now, TMT has been one of the fastest growing s...
Feb 2, 2011Novacap to be Acquired by AXA Private EquityAXA Private Equity signed an agreement with Bain Capital to acquire a majority stake in the Lyon France-based chemical group Novacap for an enterprise value of approximately €240m. The transaction, which is still subject to approval by the ...
Feb 7, 2008Novacap closes two funds totalling CAN$565mCanadian private equity firm Novacap has closed two funds: Novacap Industries III on CAN$400m and Novacap Technologies I

Reviews 0

Sign up to leave a review

Sign up Log In

FAQ about Seqens

What has the press written about Seqens?

Parsers VC has collected 10 articles mentioning Seqens, among them “Novacap Closes TMT VI at US$1.865 Billion” (Feb 17, 2021) and “NOVACAP CLOSES INDUSTRIES FUND AT C$940 MILLION” (Nov 21, 2019).

Is Seqens still active?

Yes, Seqens is active; its latest activity on Parsers VC dates from Sep 30, 2021.